Virtu Financial’s Sana Biotechnology SANA Stock Holding History

Virtu Financial’s Portfolio SANA Stock Details SANA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-109,865	Closed	-$316K	–	2165
2026 Q1	$316K	Sell	109,865 -9,447	-8%	-$37.2K	0.01%	784
2025 Q4	$486K	Buy	119,312 +78,088	+189%	+$350K	0.02%	618
2025 Q3	$146K	Buy	41,224 +18,598	+82%	+$67.2K	0.01%	976
2025 Q2	$62K	Buy	+22,626	New	+$46.7K	﹤0.01%	1110
2024 Q3	–	Sell	-11,093	Closed	-$61K	–	1822
2024 Q2	$61K	Buy	+11,093	New	+$88.4K	﹤0.01%	877
2024 Q1	–	Sell	-18,527	Closed	-$76K	–	2010
2023 Q4	$76K	Buy	18,527 +6,921	+60%	+$25.5K	0.01%	1087
2023 Q3	$45K	Buy	+11,606	New	+$62.4K	﹤0.01%	920
2021 Q3	–	Sell	-29,812	Closed	-$586K	–	1899
2021 Q2	$586K	Buy	+29,812	New	+$676K	0.06%	405

Other funds holding SANA

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Flagship Pioneering Cambridge, Massachusetts $1.54B AUM 86.39% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $181B AUM 41.77% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Marex Group London $23.6B AUM 57.16% 1-Year Est. Return

Virtu Financial's SANA Position: Q2 2026 in Review

Virtu Financial sold out of Sana Biotechnology (SANA) in Q2 2026, closing a stake of 109,865 shares — an estimated $316K sold.

Virtu Financial first reported a position in SANA in Q2 2021 and held it in 8 quarters. The position peaked at $586K in Q2 2021. 211 funds tracked by Wall St. Rank hold SANA as of Q2 2026.

Virtu Financial reported no remaining Sana Biotechnology position as of Q2 2026 after selling out during the quarter.
Virtu Financial sold 109,865 Sana Biotechnology shares in Q2 2026, an estimated $316K.
Virtu Financial first reported a position in Sana Biotechnology in Q2 2021 and held it in 8 quarters.
Virtu Financial's Sana Biotechnology position peaked at $586K in Q2 2021.
211 funds tracked by Wall St. Rank held Sana Biotechnology as of Q2 2026.

Based on Virtu Financial's 13F filing for Q2 2026, filed 13 Aug 2026.